Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Jasper Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get JSPR alerts

About Ronald Martell

Ronald Martell is recorded as Board Member and CEO at Jasper Therapeutics, Inc. (JSPR). Jasper Therapeutics, Inc. reported in an 8-K filed June 12, 2024 that Ronald Martell was appointed Class III director, effective June 6, 2024. The proxy statement of Jasper Therapeutics, Inc. reports total compensation of $2,494,099 for Ronald Martell in fiscal 2025, including a base salary of $727,272. Disclosed compensation is on record for 4 fiscal years. Jasper Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Jasper Therapeutics, Inc. includes Jeet Mahal (CEO, COO and Board Member), William Lis (CEO), Howard Hoffen (Chairman) and 7 others.

“Proposal No. 1: To elect two Class III directors to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified.”
Jasper Therapeutics, Inc. Form 8-K, filed June 12, 2024 · Read the filing

Affiliation history

Company network

Leadership on record at Jasper Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Jasper Therapeutics, Inc. (JSPR) $727,272 $2,494,099
2024 Jasper Therapeutics, Inc. (JSPR) $727,272 $3,215,003
2023 Jasper Therapeutics, Inc. (JSPR) $695,255 $3,369,990
2022 Jasper Therapeutics, Inc. (JSPR) $509,666 $5,640,190

Recent activity